[New antidepressant drugs. What side effects and interactions are to be expected?]. / Neue Antidepressiva. Mit welchen Nebenwirkungen und Interaktionen müssen Sie rechnen?
MMW Fortschr Med
; 142(49-50): 35-8, 40, 2000 Dec 07.
Article
em De
| MEDLINE
| ID: mdl-11190936
ABSTRACT
The new antidepressants, selective serotonin reuptake inhibitors (SSRI), selective serotonin noradrenalin reuptake inhibitors (SSNRI) and selective noradrenalin reuptake inhibitors (SNRI) have few clinically relevant side effects. Overall, the new antidepressants are better tolerated and cause fewer side effects than the classical tricyclic antidepressants (TCA). They have virtually no anticholinergic effects, a low level of toxicity, and produce no psychomotoric or cognitive impairment. Both the frequency and severity of gastrointestinal and CNS side effects, as well as tremor, are low. The results of the drug safety program (AMSP) confirm the good tolerability and low clinical side effects of these new substances.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transtorno Depressivo
/
Antidepressivos
Limite:
Humans
Idioma:
De
Revista:
MMW Fortschr Med
Assunto da revista:
MEDICINA
Ano de publicação:
2000
Tipo de documento:
Article